glp-1 agonists long term side effects Mapping the effectiveness and risks of receptor The expanding role of GLP-1
Description
Other groups have demonstrated that chronic systemic GIPR antagonism produces a moderate 69,70 to null 66 effect on body weight in obese mice, suggesting this is not an efficacious mechanism to pursue alone
In a separate meta-analysis, a significantly increased risk of cholelithiasis (OR 1.30
Patients need to be followed in a specialized bariatric surgery program, he explains
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
doi:10.1152/ajpendo.00069.2016 Gupta NA, Mells J, Dunham RM, et al
(2018) 97:e11946
